[1] 郑金锋.结外鼻型NK/T细胞淋巴瘤临床病理学研究进展[J].医学临床研究,2011,28(9):1763-1766.
[2] Lin N, Song Y, Zheng W, et al. A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type[J]. J Hematol Oncol, 2013, 6(1):44. .
[3] Avilés A, Neri N, Fernández R, et al. Combined therapy in untreated patients improves outcome in Nasal NK/T lymphoma: Results of a clinical trial[J]. Med Oncology, 2013, 30(3):1-5.
[4] Jiang L, Li S J, Jiang Y M, et al. The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis[J]. Leukemia & lymphoma, 2014, 55(5):1038-1048. .
[5] 朱雄增,李小秋.解读2008年恶性淋巴瘤WHO分类——T细胞和NK细胞淋巴瘤[J]. 临床与实验病理学杂志,2010,26(4):385-388. .
[6] 皋文君,刘砚燕,袁长蓉.国际肿瘤化疗药物不良反应评价系统——通用不良反应术语标准4.0版[J].肿瘤,2012,32(2):142-144. .
[7] 赖燕,刘稳.鼻腔鼻窦淋巴瘤8例误诊原因分析[J].蚌埠医学院学报,2013,38(9):1158-1160. .
[8] 陈波,李晔雄,刘清峰,等.早期结外鼻型NK/T细胞淋巴瘤疗后远期复发因素分析[J].中华放射肿瘤学杂志, 2013,22(3):175-179. .
[9] 王景文,魏立强.鼻型结外NK/T细胞淋巴瘤的诊治策略[J].白血病·淋巴瘤,2012,21(11):643-645.
[10] 徐靖,吴慧,卢晓旭.化疗联合放疗治疗鼻腔自然杀伤T细胞淋巴瘤的疗效及对血清肿瘤标志物的影响[J].中国肿瘤临床与康复,2014,21(11):1322-1324. |
2018, Vol. 35 
